The BMJ Today: Tranexamic acid and inferring significance of treatment effects

Tranexamic acid is a synthetic analog of the amino acid lysine. It is used to treat or prevent excessive blood loss during surgery and in various other medical conditions. An older analogue, epsilon aminocaproic acid, was temporarily withdrawn worldwide in 2007 after studies suggested that its use increased the risk of complications or death. Tranexamic […]

Read More…

Georg Roeggla: Nobel laureates meet young scientists

The 64th meeting of Nobel laureates in the field of medicine and physiology ended on 4 July, 2014. Thirty seven Nobel laureates and more than 600 selected young scientists from 80 countries participated in this week in Lindau, Bavaria. The objective of this meeting was to bring Nobel laureates and young researchers together to exchange ideas. […]

Read More…

Georg Röggla on a new and different perspective of dying

I have seen many people die in the nearly three decades I have worked as a clinician. I was, however, confronted with a totally different perspective of dying while attending a symposium “noch mal leben/vivere ancora [to live again]”  on palliative care at the free university of Bozen/Bolzano in South Tyrol in Italy on February […]

Read More…

Georg Röggla: on the new European Research Council president

The European Research Council (ERC) unanimously elected Prof. Helga Nowotny, an eminent social scientist, as the new ERC President on February 19th, 2010. Helga Nowotny is currently the ERC’s vice-President. She is Professor emeritus of Social Studies of Science, ETH Zurich, and Chair of the Scientific Advisory Board of Vienna University. She is also a […]

Read More…

Georg Röggla: Peter Sawicki’s dismissal

Nutrition in Critical Care Medicine was the main topic in the lectures at the ‘Wiener Intensivmedizinische Tage’ in Vienna (February 10th to 13th, 2010), one of the biggest ICU meetings in the German speaking part of Europe.  In the corridors the most discussed topic was Peter Sawicki’s dismissal as head of the German Institute for […]

Read More…

Georg Röggla on avalanches

The avalanche danger level was the second highest possible this week in most parts of the Alps. But the warning did not help: six alpinists died in avalanches within 24 hours in Austria. Although the scientific knowledge about the pathophysiology of being buried under an avalanche has improved, and the number of hospitals with technical equipment […]

Read More…

Georg Röggla: Evidence and quality in intensive care medicine

‘The H1N1 pandemic-are we prepared?’ was the first hot topic at the 22nd congress of the European society of intensive care medicine (ESICM) in Vienna from 11th to 14th October 2009. The question of whether there will there be enough intensive care facilities for critically ill patients in a second wave of the pandemic was […]

Read More…